MetaADEDB 2.0 @ LMMD
Rifamate
(KGTSLTYUUFWZNW-PPJQWWMSSA-N)
Structure
SMILES
NNC(=O)c1ccncc1.CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)c(/C=N/N4CCN(CC4)C)c(c(c2c(c3C)O)O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
Molecular Formula:
C49H65N7O13
Molecular Weight:
960.080
Log P:
5.1255
Hydrogen Bond Acceptor:
20
Hydrogen Bond Donor:
8
TPSA:
288.16
CAS Number(s):
51683-28-4
Synonym(s)
1.
Rifamate
External Link(s)
PubChem Compound135483892
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypotensionFAERS: 4US FAERS
2Anaphylactic shockFAERS: 3US FAERS
3ChillsFAERS: 3US FAERS
4VomitingFAERS: 3US FAERS
5Blood creatinine increasedFAERS: 2US FAERS
6BronchospasmFAERS: 2US FAERS
7Coagulation factor V level decreasedFAERS: 2US FAERS
8Disseminated Intravascular CoagulationFAERS: 2US FAERS
9ErythemaFAERS: 2US FAERS
10HeadacheFAERS: 2US FAERS
11NauseaFAERS: 2US FAERS
12Prothrombin level decreasedFAERS: 2US FAERS
13RhabdomyolysisFAERS: 2US FAERS
14Systemic mycosisFAERS: 2US FAERS
15ThrombocytopeniaFAERS: 2US FAERS
16ArthralgiaFAERS: 1US FAERS
17AstheniaFAERS: 1US FAERS
18ChromaturiaFAERS: 1US FAERS
19Erythrodermic psoriasisFAERS: 1US FAERS
20MalaiseFAERS: 1US FAERS
21Metabolic acidosisFAERS: 1US FAERS
22MyalgiaFAERS: 1US FAERS
23Optic NeuritisFAERS: 1US FAERS
24PolymyositisFAERS: 1US FAERS
25Septic ShockFAERS: 1US FAERS
26VertigoFAERS: 1US FAERS
27Visual ImpairmentFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.